Please login to the form below

Not currently logged in
Email:
Password:

Novimmune

This page shows the latest Novimmune news and features for those working in and with pharma, biotech and healthcare.

Orphan drugs dominate FDA's record-breaking year

Orphan drugs dominate FDA's record-breaking year

myasthenic syndrome (LEMS), Novimmune’s Gamifant (emapalumab) for primary hemophagocytic lymphohistiocytosis (HLH), Regeneron/Sanofi’s Libtayo (cemiplimab) for cutaneous squamous cell carcinoma (CSCC), and SIGA Technologies’ TPOXX (tecovirimat)

Latest news

More from news
Approximately 1 fully matching, plus 4 partially matching documents found.

Latest appointments

  • Sosei appoints CFO Sosei appoints CFO

    Prior to this, he held the same title at several other biotech companies, including Actelion and Novimmune.

  • Novimmune appoints Guillaume de Sampaïo Novimmune appoints Guillaume de Sampaïo

    Prior to joining Novimmune he served at Danish biotech firm Forward Pharma, where he created and managed its clinical development group. ... Guillaume de Sampaïo will help us to further advance Novimmune as we move closer to the market with our lead

  • Novimmune expands senior management team Novimmune expands senior management team

    Fleurant joins Novimmune with 20 years of quality expertise in life sciences, most recently having served as head of quality affairs at Alvotech, an Icelandic biosimilars specialist. ... Eduard Holdener, chairman and chief executive of Novimmune, said:

More from appointments
Approximately 2 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics